ALLOGENEIC BONE-MARROW TRANSPLANTATION IN JAPAN

Allogeneic bone marrow transplantation (BMT) is being used increasingl y to treat diverse diseases in Japan. The distinctive aspects of allog eneic BMT in Japan include the lower incidence of acute graft-versus-h ost disease, which may be attributable to less disparity in histocompa tibility antigens in Japanese. Research in the field of allogeneic BMT in Japan has covered the use of recombinant hemopoietic growth factor s, especially granulocyte colony-stimulating factor, and novel immunos uppressive agents.